CNTN1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: A relationship between CMS and dystroglycanopathies has previously been proposed (Compton et al., 2008); however, this was for a lethal form of congenital myopathy due to mutations in CNTN1 where affected individuals died at birth or shortly afterwards.